Portal:CPTAC/FeaturedPathways
From WikiPathways
(Difference between revisions)
(typo) |
(added WP4241) |
||
| Line 28: | Line 28: | ||
|- | |- | ||
|width=100px|{{#pwImage:Pathway:WP4290|250px||Metabolic reprogramming in colon cancer}} | |width=100px|{{#pwImage:Pathway:WP4290|250px||Metabolic reprogramming in colon cancer}} | ||
| + | |width=100px|{{#pwImage:Pathway:WPWP4241|250px||Type 2 papillary renal cell carcinoma}} | ||
|} | |} | ||
Revision as of 21:14, 25 May 2018
|
Image does not exist TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer |
Image does not exist PDGFR-beta pathway Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer |
Image does not exist Bladder Cancer |
Image does not exist EPO Receptor Signaling |
|
Image does not exist ErbB Signaling Pathway |
Image does not exist Interferon type I signaling pathways |
Image does not exist Transcriptional activation by NRF2 |
Image does not exist Pathways in clear cell renal cell carcinoma |
|
Image does not exist MFAP5-mediated ovarian cancer cell motility and invasiveness |
Image does not exist Endometrial cancer |
Image does not exist Tumor suppressor activity of SMARCB1 |
Image does not exist MET in type 1 Papillary renal Cell Carcinoma |
|
Image does not exist Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway |
Image does not exist Chromosomal and microsatellite instability in colorectal cancer |
Image does not exist EMT transition in Colorectal Cancer |
Image does not exist Regulation of sister chromatid separation at the metaphase-anaphase transition |
|
Image does not exist LncRNA involvement in canonical Wnt signaling and colorectal cancer |
Image does not exist Non-small cell lung cancer |
Image does not exist Pancreatic adeonocarcinoma pathway |
Image does not exist Breast cancer pathway |
|
Image does not exist Metabolic reprogramming in colon cancer |
Image does not exist Type 2 papillary renal cell carcinoma |
